PMID- 29446659 OWN - NLM STAT- MEDLINE DCOM- 20181011 LR - 20221207 IS - 1945-0257 (Electronic) IS - 1945-0257 (Linking) VI - 22 IP - 3 DP - 2018 Mar TI - Association Analysis of the Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism and Gender with Efficacy of Antidepressants in the Chinese Han Population with Generalized Anxiety Disorder. PG - 199-206 LID - 10.1089/gtmb.2017.0053 [doi] AB - BACKGROUND AND AIM: This study was designed to explore the relationship between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and antidepressants' efficacy in the Chinese Han population with generalized anxiety disorder (GAD). MATERIALS AND METHODS: We recruited 206 patients who met the diagnostic criteria for GAD into the test group, and assigned 209 healthy participants to the control group. All participants were genotyped for the BDNF Val66Met polymorphism. GAD patients were treated with escitalopram or extended-release venlafaxine. We used the Hamilton Rating Scale for Anxiety (HAM-A) to assess the response to 8-weeks of antidepressant treatment for GAD. RESULTS: We did not identify any significant differences in the allelic or genotype frequencies of the BDNF Val66Met polymorphism between the test and control group. Furthermore, we did not detect any significant difference in the allele or genotype frequency of BDNF Val66Met between patients with different treatment responses. Finally, we did not detect any significant difference in the HAM-A score reduction rate among patients with different genotypes, gender, or treatment drugs. CONCLUSIONS: No significant difference was found in the BDNF Val66Met polymorphism between patients with GAD and healthy controls, nor was this polymorphism significantly associated with antidepressant drug efficacy for GAD. FAU - Lin, Min AU - Lin M AD - 1 Department of Clinical Psychology, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Zhu, Jianying AU - Zhu J AD - 2 Department of Radiology, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Yuan, Yonggui AU - Yuan Y AD - 3 Department of Psychosomatics and Psychiatry, Affiliated ZhongDa Hospital of Southeast University , Nanjing, P.R. China . FAU - Ren, Lie AU - Ren L AD - 4 Department of Neurosis and Psychosomatic Diseases, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Qian, Mincai AU - Qian M AD - 4 Department of Neurosis and Psychosomatic Diseases, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Shen, Zhongxia AU - Shen Z AD - 4 Department of Neurosis and Psychosomatic Diseases, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Shao, Yongliang AU - Shao Y AD - 2 Department of Radiology, Huzhou 3rd Hospital , Huzhou, P.R. China . FAU - Shen, Xinhua AU - Shen X AD - 4 Department of Neurosis and Psychosomatic Diseases, Huzhou 3rd Hospital , Huzhou, P.R. China . LA - eng PT - Journal Article DEP - 20180215 PL - United States TA - Genet Test Mol Biomarkers JT - Genetic testing and molecular biomarkers JID - 101494210 RN - 0 (Antidepressive Agents) RN - 0 (Brain-Derived Neurotrophic Factor) RN - AE28F7PNPL (Methionine) RN - HG18B9YRS7 (Valine) SB - IM MH - Adult MH - Antidepressive Agents/*therapeutic use MH - Anxiety/*drug therapy/ethnology/*genetics MH - Asian People/*genetics MH - Brain-Derived Neurotrophic Factor/*genetics MH - China MH - Female MH - Genotype MH - Humans MH - Male MH - Methionine/*genetics MH - Middle Aged MH - Patient Health Questionnaire MH - *Polymorphism, Single Nucleotide MH - Treatment Outcome MH - Valine/*genetics OTO - NOTNLM OT - antidepressant efficacy OT - brain-derived neurotrophic factor OT - generalized anxiety disorder OT - single nucleotide polymorphism EDAT- 2018/02/16 06:00 MHDA- 2018/10/12 06:00 CRDT- 2018/02/16 06:00 PHST- 2018/02/16 06:00 [pubmed] PHST- 2018/10/12 06:00 [medline] PHST- 2018/02/16 06:00 [entrez] AID - 10.1089/gtmb.2017.0053 [doi] PST - ppublish SO - Genet Test Mol Biomarkers. 2018 Mar;22(3):199-206. doi: 10.1089/gtmb.2017.0053. Epub 2018 Feb 15.